Kinetic features of TCR:MHC/peptide interactions dictate their outcome in v
itro, some important parameters of which include the number of molecules en
gaged and the duration of engagement. We explored the in vivo significance
of these findings in transgenic mice expressing TCRs in a quantitatively an
d temporally controlled manner. As anticipated, reduced TCR levels resulted
in attenuated reactivity, but response thresholds were substantially lower
than expected-at as low as 1/20(th), the normal TCR numbers and with no in
dication of phenotypic skewing at suboptimal levels. We also studied surviv
al of T lymphocytes stripped of their TCRs. Unlike B cells, T cells lacking
antigen receptors did not die precipitously; instead, populations decayed
gradually, just as previously reported in the absence of MHC molecules.